Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema.
Identifieur interne : 004B69 ( Main/Exploration ); précédent : 004B68; suivant : 004B70Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema.
Auteurs : Shinya Kashiwagi [Japon] ; Kanako Hosono ; Tatsunori Suzuki ; Akira Takeda ; Eiju Uchinuma ; Masataka MajimaSource :
- Laboratory investigation; a journal of technical methods and pathology [ 1530-0307 ] ; 2011.
Descripteurs français
- KwdFr :
- MESH :
- enzymologie : Lymphoedème.
- métabolisme : Cyclooxygenase 2.
- physiologie : Lymphangiogenèse.
- physiopathologie : Lymphoedème, Vaisseaux lymphatiques.
- Amorces ADN, Animaux, Cicatrisation de plaie, Mâle, RT-PCR, Souris, Souris de lignée C57BL, Séquence nucléotidique.
English descriptors
- KwdEn :
- MESH :
- chemical , metabolism : Cyclooxygenase 2.
- enzymology : Lymphedema.
- physiology : Lymphangiogenesis.
- physiopathology : Lymphatic Vessels, Lymphedema.
- Animals, Base Sequence, DNA Primers, Male, Mice, Mice, Inbred C57BL, Reverse Transcriptase Polymerase Chain Reaction, Wound Healing.
Abstract
The pathophysiology of secondary lymphedema remains poorly understood. To clarify the roles of cyclooxygenase (COX)-2 in enhancement of lymphangiogenesis during secondary lymphedema, we tested a mouse tail model and evaluated the recurrence of lymph flow. To induce lymphedema, a circumferential incision was made in the tail of anesthetized mice to sever the dermal lymphatic vessels. The maximum diameters of the tails were measured weekly. We found that the diameters of the tails around the wounds were markedly increased after surgery, and reached maximum size 2 weeks after wounding in mice without a COX-2 inhibitor, celecoxib (Celecoxib-). Expression of COX-2 in wound granulation tissues was markedly increased 1 week after surgery compared with unwounded naive control mice. In Celecoxib-, recurrence of lymphatic flow in the wound granulation tissues was detected 3 weeks after surgical treatment. In contrast, lymphatic flow was markedly suppressed in mice treated with celecoxib (Celecoxib+). Newly formed lymphatic structures were identified in the granulation tissues formed at wounded lesions in Celecoxib-, whereas those were markedly suppressed in Celecoxib+. Interstitial tissue pressures in the distal areas of the tail wounds were markedly increased in Celecoxib+ with reduced expression of vascular endothelial cell growth factor (VEGF)-C. F4/80-positive cells were accumulated to the wound granulation tissues in Celecoxib-, and the accumulation of these cells was suppressed in Celecoxib+. Prostaglandin E(2) (PGE(2)) upregulated the expressions of VEGF-A and VEGF-C in cultured macrophages, but not human lymphatic microvascular endothelial cells. The present study therefore suggests that lymphangiogenesis, together with recurrence of lymph flow after surgical induction of lymphedema, is upregulated by COX-2 possibly via generation of PGs.
DOI: 10.1038/labinvest.2011.84
PubMed: 21577211
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002626
- to stream PubMed, to step Curation: 002626
- to stream PubMed, to step Checkpoint: 002626
- to stream Ncbi, to step Merge: 004356
- to stream Ncbi, to step Curation: 004356
- to stream Ncbi, to step Checkpoint: 004356
- to stream Main, to step Merge: 004C01
- to stream Main, to step Curation: 004B69
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema.</title>
<author><name sortKey="Kashiwagi, Shinya" sort="Kashiwagi, Shinya" uniqKey="Kashiwagi S" first="Shinya" last="Kashiwagi">Shinya Kashiwagi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacology, Kitasato University School of Medicine, Kanagawa, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Pharmacology, Kitasato University School of Medicine, Kanagawa</wicri:regionArea>
<wicri:noRegion>Kanagawa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hosono, Kanako" sort="Hosono, Kanako" uniqKey="Hosono K" first="Kanako" last="Hosono">Kanako Hosono</name>
</author>
<author><name sortKey="Suzuki, Tatsunori" sort="Suzuki, Tatsunori" uniqKey="Suzuki T" first="Tatsunori" last="Suzuki">Tatsunori Suzuki</name>
</author>
<author><name sortKey="Takeda, Akira" sort="Takeda, Akira" uniqKey="Takeda A" first="Akira" last="Takeda">Akira Takeda</name>
</author>
<author><name sortKey="Uchinuma, Eiju" sort="Uchinuma, Eiju" uniqKey="Uchinuma E" first="Eiju" last="Uchinuma">Eiju Uchinuma</name>
</author>
<author><name sortKey="Majima, Masataka" sort="Majima, Masataka" uniqKey="Majima M" first="Masataka" last="Majima">Masataka Majima</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21577211</idno>
<idno type="pmid">21577211</idno>
<idno type="doi">10.1038/labinvest.2011.84</idno>
<idno type="wicri:Area/PubMed/Corpus">002626</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002626</idno>
<idno type="wicri:Area/PubMed/Curation">002626</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002626</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002626</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002626</idno>
<idno type="wicri:Area/Ncbi/Merge">004356</idno>
<idno type="wicri:Area/Ncbi/Curation">004356</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004356</idno>
<idno type="wicri:Area/Main/Merge">004C01</idno>
<idno type="wicri:Area/Main/Curation">004B69</idno>
<idno type="wicri:Area/Main/Exploration">004B69</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema.</title>
<author><name sortKey="Kashiwagi, Shinya" sort="Kashiwagi, Shinya" uniqKey="Kashiwagi S" first="Shinya" last="Kashiwagi">Shinya Kashiwagi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacology, Kitasato University School of Medicine, Kanagawa, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Pharmacology, Kitasato University School of Medicine, Kanagawa</wicri:regionArea>
<wicri:noRegion>Kanagawa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hosono, Kanako" sort="Hosono, Kanako" uniqKey="Hosono K" first="Kanako" last="Hosono">Kanako Hosono</name>
</author>
<author><name sortKey="Suzuki, Tatsunori" sort="Suzuki, Tatsunori" uniqKey="Suzuki T" first="Tatsunori" last="Suzuki">Tatsunori Suzuki</name>
</author>
<author><name sortKey="Takeda, Akira" sort="Takeda, Akira" uniqKey="Takeda A" first="Akira" last="Takeda">Akira Takeda</name>
</author>
<author><name sortKey="Uchinuma, Eiju" sort="Uchinuma, Eiju" uniqKey="Uchinuma E" first="Eiju" last="Uchinuma">Eiju Uchinuma</name>
</author>
<author><name sortKey="Majima, Masataka" sort="Majima, Masataka" uniqKey="Majima M" first="Masataka" last="Majima">Masataka Majima</name>
</author>
</analytic>
<series><title level="j">Laboratory investigation; a journal of technical methods and pathology</title>
<idno type="eISSN">1530-0307</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Base Sequence</term>
<term>Cyclooxygenase 2 (metabolism)</term>
<term>DNA Primers</term>
<term>Lymphangiogenesis (physiology)</term>
<term>Lymphatic Vessels (physiopathology)</term>
<term>Lymphedema (enzymology)</term>
<term>Lymphedema (physiopathology)</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Amorces ADN</term>
<term>Animaux</term>
<term>Cicatrisation de plaie</term>
<term>Cyclooxygenase 2 (métabolisme)</term>
<term>Lymphangiogenèse (physiologie)</term>
<term>Lymphoedème (enzymologie)</term>
<term>Lymphoedème (physiopathologie)</term>
<term>Mâle</term>
<term>RT-PCR</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Séquence nucléotidique</term>
<term>Vaisseaux lymphatiques (physiopathologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cyclooxygenase 2</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Cyclooxygenase 2</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Lymphangiogenèse</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Lymphangiogenesis</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Lymphoedème</term>
<term>Vaisseaux lymphatiques</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphatic Vessels</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Base Sequence</term>
<term>DNA Primers</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Amorces ADN</term>
<term>Animaux</term>
<term>Cicatrisation de plaie</term>
<term>Mâle</term>
<term>RT-PCR</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Séquence nucléotidique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The pathophysiology of secondary lymphedema remains poorly understood. To clarify the roles of cyclooxygenase (COX)-2 in enhancement of lymphangiogenesis during secondary lymphedema, we tested a mouse tail model and evaluated the recurrence of lymph flow. To induce lymphedema, a circumferential incision was made in the tail of anesthetized mice to sever the dermal lymphatic vessels. The maximum diameters of the tails were measured weekly. We found that the diameters of the tails around the wounds were markedly increased after surgery, and reached maximum size 2 weeks after wounding in mice without a COX-2 inhibitor, celecoxib (Celecoxib-). Expression of COX-2 in wound granulation tissues was markedly increased 1 week after surgery compared with unwounded naive control mice. In Celecoxib-, recurrence of lymphatic flow in the wound granulation tissues was detected 3 weeks after surgical treatment. In contrast, lymphatic flow was markedly suppressed in mice treated with celecoxib (Celecoxib+). Newly formed lymphatic structures were identified in the granulation tissues formed at wounded lesions in Celecoxib-, whereas those were markedly suppressed in Celecoxib+. Interstitial tissue pressures in the distal areas of the tail wounds were markedly increased in Celecoxib+ with reduced expression of vascular endothelial cell growth factor (VEGF)-C. F4/80-positive cells were accumulated to the wound granulation tissues in Celecoxib-, and the accumulation of these cells was suppressed in Celecoxib+. Prostaglandin E(2) (PGE(2)) upregulated the expressions of VEGF-A and VEGF-C in cultured macrophages, but not human lymphatic microvascular endothelial cells. The present study therefore suggests that lymphangiogenesis, together with recurrence of lymph flow after surgical induction of lymphedema, is upregulated by COX-2 possibly via generation of PGs.</div>
</front>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><noCountry><name sortKey="Hosono, Kanako" sort="Hosono, Kanako" uniqKey="Hosono K" first="Kanako" last="Hosono">Kanako Hosono</name>
<name sortKey="Majima, Masataka" sort="Majima, Masataka" uniqKey="Majima M" first="Masataka" last="Majima">Masataka Majima</name>
<name sortKey="Suzuki, Tatsunori" sort="Suzuki, Tatsunori" uniqKey="Suzuki T" first="Tatsunori" last="Suzuki">Tatsunori Suzuki</name>
<name sortKey="Takeda, Akira" sort="Takeda, Akira" uniqKey="Takeda A" first="Akira" last="Takeda">Akira Takeda</name>
<name sortKey="Uchinuma, Eiju" sort="Uchinuma, Eiju" uniqKey="Uchinuma E" first="Eiju" last="Uchinuma">Eiju Uchinuma</name>
</noCountry>
<country name="Japon"><noRegion><name sortKey="Kashiwagi, Shinya" sort="Kashiwagi, Shinya" uniqKey="Kashiwagi S" first="Shinya" last="Kashiwagi">Shinya Kashiwagi</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004B69 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004B69 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:21577211 |texte= Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21577211" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |